Influenza has all but disappeared in 2020, but once it inevitably returns GPs will have access to a new type of vaccine that could help save...
Significant progress has been made, but experts say the country still has a long way to go to meet the 2022 target of virtual elimination.
The condition is also more likely in those who, among other things, had more than five symptoms in the first week of illness.
New data released by the ABS provides insight into COVID-19 deaths throughout the country.
A proposed UK vaccine trial that will infect healthy volunteers has raised concern among Australian experts who fear long-term health ramifications.
Three recently published papers give more insight into the coronavirus’ impact on the heart – and what doctors can do to help.
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
Researchers say the findings are just as concerning for those being treated with antihypertensives with a systolic blood pressure below 120 mmHg.
With falling screening rates and concerns of a wave of post-COVID diagnoses, further preventive health incentives have been put in place.
The ‘investigational antibody cocktail’ given to the US President is yet to pass clinical trials, but early signs are positive.